Posting of Shareholder Circular

RNS Number : 8101H

Genedrive PLC

19 November 2018

 

19 November 2018

genedrive plc ("genedrive" or the "Company")

Posting of Shareholder Circular

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, confirms that further to the announcement made on 16 November 2018, a Circular has been published and will be posted to shareholders today in relation to the proposed Placing of 15,217,391 new Ordinary Shares at 23 pence per share raising £3.5 million, the issue of £2.5 million convertible Loan Notes and a broker option of up to £0.5 million through the issue of up to 2,173,913 additional new Ordinary Shares. The circular contains the notice convening the General Meeting to be held at the offices of the Company: The Incubator Building, 48 Grafton Street, Manchester, M13 9XX at 12 noon on 7 December 2018.

A copy of the Circular will shortly be available on the Company's website at the following URL: www.genedriveplc.com.

-  Ends -

For further details please contact:

genedrive plc David Budd: CEO Matthew Fowler: CFO		[phone]
Peel Hunt LLP James Steel Oliver Jackson		[phone]
Stanford Capital Partners Limited Patrick Claridge		[phone]
John Howes
Consilium Strategic Communications Chris Gardner Matthew Neal Laura Thornton		[phone] [e-mail]

Notes to Editors

About genedrive

genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Genedrive® HCV-ID test has received CE-IVD Certification and has been launched in Africa and Asia Pacific. genedrive has distribution agreements with subsidiaries of Sysmex Corporation for the distribution of the Genedrive® platform in the EMEA and SE Asia (ex-India), and with ARKRAY Healthcare pvt Ltd for the distribution of the Genedrive® HCV-ID Kit and Genedrive® platform in India. Further details can be found at: www.genedriveplc.com and www.genedrive.com. The Company also has tests in development for tuberculosis (mTB) and Antibiotic Induced Hearing Loss (AIHL).

 

END

 

 

CIREKLFFVFFLFBZ